Drug treatment of cancer cell lines

A way to select for cancer stem cells?

Ilaria Chiodi, Cristina Belgiovine, Francesca Donà, A. Ivana Scovassi, Chiara Mondello

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Tumors are generally composed of different cell types. In recent years, it has been shown that in many types of cancers a subset of cells show peculiar characteristics, such as the ability to induce tumors when engrafted into host animals, self-renew and being immortal, and give rise to a differentiated progeny. These cells have been defined as cancer stem cells (CSCs) or tumor initiating cells. CSCs can be isolated both from tumor specimens and established cancer cell lines on the basis of their ability to exclude fluorescent dyes, express specific cell surface markers or grow in particular culture conditions. A key feature of CSCs is their resistance to chemotherapeutic agents, which could contribute to the remaining of residual cancer cells after therapeutic treatments. It has been shown that CSC-like cells can be isolated after drug treatment of cancer cell lines; in this review, we will describe the strategies so far applied to identify and isolate CSCs. Furthermore, we will discuss the possible use of these selected populations to investigate CSC biology and develop new anticancer drugs.

Original languageEnglish
Pages (from-to)1111-1128
Number of pages18
JournalCancers
Volume3
Issue number1
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Neoplastic Stem Cells
Cell Line
Pharmaceutical Preparations
Neoplasms
Therapeutics
Residual Neoplasm
Fluorescent Dyes
Cell Biology
Population

Keywords

  • Cancer
  • Chemotherapy
  • Drug resistance
  • Stem cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Drug treatment of cancer cell lines : A way to select for cancer stem cells? / Chiodi, Ilaria; Belgiovine, Cristina; Donà, Francesca; Scovassi, A. Ivana; Mondello, Chiara.

In: Cancers, Vol. 3, No. 1, 03.2011, p. 1111-1128.

Research output: Contribution to journalArticle

Chiodi, I, Belgiovine, C, Donà, F, Scovassi, AI & Mondello, C 2011, 'Drug treatment of cancer cell lines: A way to select for cancer stem cells?', Cancers, vol. 3, no. 1, pp. 1111-1128. https://doi.org/10.3390/cancers3011111
Chiodi, Ilaria ; Belgiovine, Cristina ; Donà, Francesca ; Scovassi, A. Ivana ; Mondello, Chiara. / Drug treatment of cancer cell lines : A way to select for cancer stem cells?. In: Cancers. 2011 ; Vol. 3, No. 1. pp. 1111-1128.
@article{bffad33ab0cb4bd793c95386c6ce63c7,
title = "Drug treatment of cancer cell lines: A way to select for cancer stem cells?",
abstract = "Tumors are generally composed of different cell types. In recent years, it has been shown that in many types of cancers a subset of cells show peculiar characteristics, such as the ability to induce tumors when engrafted into host animals, self-renew and being immortal, and give rise to a differentiated progeny. These cells have been defined as cancer stem cells (CSCs) or tumor initiating cells. CSCs can be isolated both from tumor specimens and established cancer cell lines on the basis of their ability to exclude fluorescent dyes, express specific cell surface markers or grow in particular culture conditions. A key feature of CSCs is their resistance to chemotherapeutic agents, which could contribute to the remaining of residual cancer cells after therapeutic treatments. It has been shown that CSC-like cells can be isolated after drug treatment of cancer cell lines; in this review, we will describe the strategies so far applied to identify and isolate CSCs. Furthermore, we will discuss the possible use of these selected populations to investigate CSC biology and develop new anticancer drugs.",
keywords = "Cancer, Chemotherapy, Drug resistance, Stem cells",
author = "Ilaria Chiodi and Cristina Belgiovine and Francesca Don{\`a} and Scovassi, {A. Ivana} and Chiara Mondello",
year = "2011",
month = "3",
doi = "10.3390/cancers3011111",
language = "English",
volume = "3",
pages = "1111--1128",
journal = "Cancers",
issn = "2072-6694",
publisher = "MDPI AG",
number = "1",

}

TY - JOUR

T1 - Drug treatment of cancer cell lines

T2 - A way to select for cancer stem cells?

AU - Chiodi, Ilaria

AU - Belgiovine, Cristina

AU - Donà, Francesca

AU - Scovassi, A. Ivana

AU - Mondello, Chiara

PY - 2011/3

Y1 - 2011/3

N2 - Tumors are generally composed of different cell types. In recent years, it has been shown that in many types of cancers a subset of cells show peculiar characteristics, such as the ability to induce tumors when engrafted into host animals, self-renew and being immortal, and give rise to a differentiated progeny. These cells have been defined as cancer stem cells (CSCs) or tumor initiating cells. CSCs can be isolated both from tumor specimens and established cancer cell lines on the basis of their ability to exclude fluorescent dyes, express specific cell surface markers or grow in particular culture conditions. A key feature of CSCs is their resistance to chemotherapeutic agents, which could contribute to the remaining of residual cancer cells after therapeutic treatments. It has been shown that CSC-like cells can be isolated after drug treatment of cancer cell lines; in this review, we will describe the strategies so far applied to identify and isolate CSCs. Furthermore, we will discuss the possible use of these selected populations to investigate CSC biology and develop new anticancer drugs.

AB - Tumors are generally composed of different cell types. In recent years, it has been shown that in many types of cancers a subset of cells show peculiar characteristics, such as the ability to induce tumors when engrafted into host animals, self-renew and being immortal, and give rise to a differentiated progeny. These cells have been defined as cancer stem cells (CSCs) or tumor initiating cells. CSCs can be isolated both from tumor specimens and established cancer cell lines on the basis of their ability to exclude fluorescent dyes, express specific cell surface markers or grow in particular culture conditions. A key feature of CSCs is their resistance to chemotherapeutic agents, which could contribute to the remaining of residual cancer cells after therapeutic treatments. It has been shown that CSC-like cells can be isolated after drug treatment of cancer cell lines; in this review, we will describe the strategies so far applied to identify and isolate CSCs. Furthermore, we will discuss the possible use of these selected populations to investigate CSC biology and develop new anticancer drugs.

KW - Cancer

KW - Chemotherapy

KW - Drug resistance

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=79953725145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953725145&partnerID=8YFLogxK

U2 - 10.3390/cancers3011111

DO - 10.3390/cancers3011111

M3 - Article

VL - 3

SP - 1111

EP - 1128

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 1

ER -